GenMark Dx's mission is to become the market leader in providing high value, simple to perform, clinically relevant multiplex molecular tests to aid in the diagnosis of disease and the selection and dosing of therapies.
For investor information, please contact IR@genmarkdx.com.
Feb 23, 2015
GenMark Announces Appointment of New Board Members
Mar 4, 2015 at 9:20 AM ET
Cowen and Company's 35th Annual Health Care Conference
Mar 2, 2015 at 2:50 PM ET
Raymond James' 36th Annual Institutional Investors Conference